Status:
COMPLETED
Central Venous Access Device Removal in Cancer Patients
Lead Sponsor:
General Hospital Groeninge
Conditions:
Oncology
Haematological Malignancy
Eligibility:
All Genders
Brief Summary
Background: Central venous catheters are frequently used during cancer treatment with the aim of venepreservation. It can facilitate venous access for the safe administration of irritating or vesican...
Eligibility Criteria
Inclusion
- Central venous access device removal in our general hospital
- Cancer patient
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
1402 Patients enrolled
Trial Details
Trial ID
NCT03855969
Start Date
March 1 2019
End Date
December 30 2019
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GHGroeninge
Kortrijk, Belgium